<?xml version="1.0" encoding="UTF-8"?>
<ref id="RSOB200174C45">
 <label>45</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Garraud</surname>
    <given-names>O</given-names>
   </name>, 
   <name name-style="western">
    <surname>Heshmati</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Pozzetto</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Lefrere</surname>
    <given-names>F</given-names>
   </name>, 
   <name name-style="western">
    <surname>Girot</surname>
    <given-names>R</given-names>
   </name>, 
   <name name-style="western">
    <surname>Saillol</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Laperche</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <year>2016</year>
  <article-title>Plasma therapy against infectious pathogens, as of yesterday, today and tomorrow</article-title>. 
  <source>Transfus. Clin. Biol.</source>
  <volume>23</volume>, 
  <fpage>39</fpage>â€“
  <lpage>44</lpage>. (
  <pub-id pub-id-type="doi">10.1016/j.tracli.2015.12.003</pub-id>)
  <pub-id pub-id-type="pmid">26775794</pub-id>
 </mixed-citation>
</ref>
